| Project/Area Number |
21790832
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Neurology
|
|---|
| Research Institution | Yamagata University |
|---|
Principal Investigator |
KOYAMA Shingo 山形大学, 大学院・医学系研究科, 助教 (30436208)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Fiscal Year 2011: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2010: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | 神経分子病態学 / パーキンソン病 / αシヌクレイン / 神経変性疾患 / ドパミン代謝 |
|---|
| Research Abstract |
We studied the effect of alpha-synuclein (aS) on dopamine transporter (DAT)-mediated dopamine or 6-hydroxydopamine (6-OHDA) toxicity using aS-inducible, DAT stably expressing PC12 cells or aS and DAT stably expressing SH-SY5Y cells. To induce expression of aS, differentiated PC12 cells were incubated with or without doxycycline for 5 fays. Thereafter, PC12 cells were incubated with 500 mM dopamine for 24 h and we assessed cell viability by trypan blue staining. No difference in cell viability was detected between doxycycline-induced and non-induced cells. Secondary, we studied the DAT-mediated 6-hydroxydopamine toxicity, DAT/aS or GFP/aS expressing SH-SY5Y cells were incubated with 200 μM 6-OHDA for 4 hours. No difference in cell viability was detected between DAT-aS and GFP-aS expressing SH-SY5Y cells. Therefore, we could not detect the effect of aS on DAT-mediated cell toxicity mechanism in our experimental system.
|
